Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency
Status:
Completed
Trial end date:
2003-03-05
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
evaluate the safety profiles of Norditropin® (lyophilized somatropin) and Norditropin®
cartridges (liquid somatropin) in children with growth hormone deficiency.